0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > EphA5

EphA5

Brief Information

Name:EPH Receptor A5
Target Synonym:EPHA5,BSK,EphA5,EC 2.7.10,Receptor Protein-Tyrosine Kinase HEK7,Tyrosine-Protein Kinase Receptor EHK-1,Epididymis Secretory Sperm Binding Protein,EK7,Hek7,EHK-1,EC 2.7.10.1,EPH-like kinase 7,EPH-Like Kinase,EPH homology kinase 1,Brain-Specific Kinase,EPH Homology Kinase,Ephrin type-A receptor 5,Ephrin Type-A Receptor,HEK7,CEK7,EHK1,TYRO4
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
EP5-H52H5 Human Human EphA5 Protein, His Tag (MALS & SPR verified)
EP5-H52H5-structure
EP5-H52H5-sds
ACRO Quality

Part of Bioactivity data

EP5-H52H5-SPR
 EphA5 SPR

Human Ephrin-A3, Fc Tag (Cat. No. EA3-H5258) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human EphA5, His Tag (Cat. No. EP5-H52H5) with an affinity constant of 0.576 μM as determined in a SPR assay (Biacore 8K) (QC tested).

EP5-H52H5-MALS-HPLC
EphA5 MALS images

The purity of Human EphA5, His Tag (Cat. No. EP5-H52H5) is more than 95% and the molecular weight of this protein is around 65-80 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
MBRC-101 MBRC-101 Phase 1 Clinical MBrace Therapeutics Inc Neoplasms Details
MBRC-101 MBRC-101 Phase 1 Clinical MBrace Therapeutics Inc Neoplasms Details

This web search service is supported by Google Inc.

totop

Nachricht schicken